DAVID E I PYOTT Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID E I PYOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID E I PYOTT. DAVID E I PYOTT is Chairman of the Board and CEO in ALLERGAN INC ($AGN) and Director in Avery Dennison Corp ($AVY) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in PLIANT THERAPEUTICS, INC. ($PLRX).
DAVID E I PYOTT in BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID E I PYOTT: Director
Holdings: 29,840 shares
Current Value: $2,653,074
Latest Transaction: Sep 01 2020
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID E I PYOTT in BIOMARIN PHARMACEUTICAL INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, ALNY, AVY, BMRN, PLRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.84 | 900 | 70,955 | 30,740 | 29.8 K to 30.7 K (+3.02 %) |
| Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.22 | 11,900 | 930,760 | 29,840 | 17.9 K to 29.8 K (+66.33 %) |
| Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.84 | 900 | 70,955 | 30,740 | 29.8 K to 30.7 K (+3.02 %) |
| Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.22 | 11,900 | 930,760 | 29,840 | 17.9 K to 29.8 K (+66.33 %) |
| May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 17,940 | 13.6 K to 17.9 K (+31.52 %) |
| Jun 06 2019 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,430 | 0 | 13,640 | 9.2 K to 13.6 K (+48.10 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 9,210 | 4.9 K to 9.2 K (+87.58 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 2,050 | 0 | 4,910 | 2.9 K to 4.9 K (+71.68 %) |
| Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 89.52 | 2,220 | 198,734 | 2,220 | |
| Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 760 | 0 | 2,860 | 2.1 K to 2.9 K (+36.19 %) |
| Jan 06 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 104.92 | 6,100 | 640,012 | 6,100 | |
| Jan 06 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 2,100 | 0 | 2,100 | 0 to 2.1 K |
Page: 1